Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$861.3M
Avg Funding
$34.5M
Global Reach
8
countries

Top Cities for Biopharma

Wellesley
Palo Alto
Singapore
San Diego
Nantes
Santa Barbara

Recently Funded Companies

Export
Wellesley, United States

Atacama Therapeutics focuses on developing treatments for hyperhidrosis.

$830K raised
May 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

$200.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.

May 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development.

$11.8M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Nantes, France

InFlectis BioScience is a private drug discovery company aiming at targeting.

$650K raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Santa Barbara, United States

Dimer Instruments designs and produces devices for real-time data monitoring and quality assurance in pharmaceutical manufacturing.

$6.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Austin, United States

TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.

$4.8M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

YonedaLabs is an AI-based software that assists chemists in optimizing reaction parameters such as temperature, concentration, and catalyst.

$4.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

$16.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.

$31.3M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Princeton, United States

Aruka Bio is a healthcare company.

$3.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Scotland, United States

Glen Clova Scientific is a company that developing a new gneration of active biological drugs.

$5.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Liège, Belgium

EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles.

$16.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Boston, United States

Acta Pharmaceuticals is a pharmaceutical company.

$13.4M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

$280.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Raleigh, United States

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.

$2.5M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Farmington, United States

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

$6.6M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Yuanbo Biotechnology is a provider of clever AI-driven cell manufacturing systems.

$1.3M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Uruma, Japan

FullStem is a company specializing in high-density mass culture technology for stem cells.

Apr 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

$52.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Sheffield, United Kingdom

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

$202K raised
Apr 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

$132.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland

Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

$63.0M raised
Apr 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

MCAL Therapeutics is a biotechnology company that develops treatment for ophthalmic diseases.

$5.9M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Atlanta, United States

Andson Biotech provides process analytical technologies for advanced therapies

$3.6M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Showing 576 to 600 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$34.5M
Total Funding Tracked
$861.3M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
3 companies$195.8M
2.Palo Alto
2 companies$216.5M
3.San Francisco
2 companies$9.9M
4.Wellesley
1 companies$830K
5.Singapore
1 companiesUndisclosed

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

915 Biopharma Startups (2026) — Recently Funded — Page 24 | VCBacked